nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—ABCC1—Rifampicin—leprosy	0.543	1	CbGbCtD
Epirubicin—AURKA—Menadione—Thalidomide—leprosy	0.0067	0.723	CbGdCrCtD
Epirubicin—CHD1—tendon—leprosy	0.00344	0.0813	CbGeAlD
Epirubicin—YWHAG—eye—leprosy	0.00321	0.076	CbGeAlD
Epirubicin—DHCR7—skin of body—leprosy	0.00305	0.072	CbGeAlD
Epirubicin—CHD1—testis—leprosy	0.00285	0.0673	CbGeAlD
Epirubicin—CHD1—nervous system—leprosy	0.00279	0.0661	CbGeAlD
Epirubicin—AURKA—tendon—leprosy	0.00277	0.0656	CbGeAlD
Epirubicin—Lymphopenia—Thalidomide—leprosy	0.00273	0.00672	CcSEcCtD
Epirubicin—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00273	0.00672	CcSEcCtD
Epirubicin—Skin exfoliation—Dapsone—leprosy	0.0026	0.00642	CcSEcCtD
Epirubicin—Venous thrombosis—Thalidomide—leprosy	0.00259	0.00638	CcSEcCtD
Epirubicin—TOP2A—Menadione—Thalidomide—leprosy	0.00256	0.276	CbGdCrCtD
Epirubicin—Vesiculobullous rash—Thalidomide—leprosy	0.00249	0.00614	CcSEcCtD
Epirubicin—Gastric ulcer—Thalidomide—leprosy	0.0024	0.00592	CcSEcCtD
Epirubicin—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.0024	0.00592	CcSEcCtD
Epirubicin—Febrile neutropenia—Thalidomide—leprosy	0.00232	0.00572	CcSEcCtD
Epirubicin—Enlargement abdomen—Thalidomide—leprosy	0.00232	0.00572	CcSEcCtD
Epirubicin—AURKA—testis—leprosy	0.00229	0.0543	CbGeAlD
Epirubicin—Serum creatinine increased—Thalidomide—leprosy	0.00227	0.00559	CcSEcCtD
Epirubicin—AURKA—nervous system—leprosy	0.00225	0.0533	CbGeAlD
Epirubicin—Psoriasis—Thalidomide—leprosy	0.00222	0.00547	CcSEcCtD
Epirubicin—Myasthenia—Thalidomide—leprosy	0.00222	0.00547	CcSEcCtD
Epirubicin—Oral candidiasis—Thalidomide—leprosy	0.0022	0.00542	CcSEcCtD
Epirubicin—Hypomagnesaemia—Thalidomide—leprosy	0.0022	0.00542	CcSEcCtD
Epirubicin—Embolism—Thalidomide—leprosy	0.00218	0.00536	CcSEcCtD
Epirubicin—Nail disorder—Thalidomide—leprosy	0.00215	0.00531	CcSEcCtD
Epirubicin—YWHAG—tendon—leprosy	0.00213	0.0503	CbGeAlD
Epirubicin—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00205	0.00505	CcSEcCtD
Epirubicin—Burning sensation—Thalidomide—leprosy	0.00201	0.00495	CcSEcCtD
Epirubicin—Neuralgia—Thalidomide—leprosy	0.00201	0.00495	CcSEcCtD
Epirubicin—Hypercalcaemia—Thalidomide—leprosy	0.00201	0.00495	CcSEcCtD
Epirubicin—Hepatomegaly—Thalidomide—leprosy	0.00197	0.00486	CcSEcCtD
Epirubicin—Lung disorder—Thalidomide—leprosy	0.00197	0.00486	CcSEcCtD
Epirubicin—Thrombosis—Thalidomide—leprosy	0.00197	0.00486	CcSEcCtD
Epirubicin—Nystagmus—Thalidomide—leprosy	0.00196	0.00482	CcSEcCtD
Epirubicin—Hyperlipidaemia—Thalidomide—leprosy	0.00194	0.00477	CcSEcCtD
Epirubicin—DHCR7—testis—leprosy	0.00192	0.0454	CbGeAlD
Epirubicin—DHCR7—nervous system—leprosy	0.00188	0.0446	CbGeAlD
Epirubicin—Neuritis—Thalidomide—leprosy	0.00187	0.00461	CcSEcCtD
Epirubicin—Albuminuria—Thalidomide—leprosy	0.00187	0.00461	CcSEcCtD
Epirubicin—Pleural effusion—Thalidomide—leprosy	0.00182	0.00449	CcSEcCtD
Epirubicin—Amblyopia—Thalidomide—leprosy	0.00181	0.00446	CcSEcCtD
Epirubicin—Skin ulcer—Thalidomide—leprosy	0.00179	0.00442	CcSEcCtD
Epirubicin—Hyperaesthesia—Thalidomide—leprosy	0.00178	0.00438	CcSEcCtD
Epirubicin—Nasopharyngitis—Dapsone—leprosy	0.00177	0.00436	CcSEcCtD
Epirubicin—YWHAG—testis—leprosy	0.00176	0.0417	CbGeAlD
Epirubicin—Rash pustular—Thalidomide—leprosy	0.00175	0.00431	CcSEcCtD
Epirubicin—Muscular weakness—Dapsone—leprosy	0.00175	0.0043	CcSEcCtD
Epirubicin—YWHAG—nervous system—leprosy	0.00173	0.0409	CbGeAlD
Epirubicin—Influenza—Dapsone—leprosy	0.00171	0.00422	CcSEcCtD
Epirubicin—Petechiae—Thalidomide—leprosy	0.0017	0.00418	CcSEcCtD
Epirubicin—Pancreatitis—Dapsone—leprosy	0.00168	0.00413	CcSEcCtD
Epirubicin—Blood disorder—Thalidomide—leprosy	0.00167	0.00412	CcSEcCtD
Epirubicin—UGT2B7—testis—leprosy	0.00159	0.0376	CbGeAlD
Epirubicin—Vasodilation procedure—Thalidomide—leprosy	0.00159	0.00392	CcSEcCtD
Epirubicin—Jaundice cholestatic—Thalidomide—leprosy	0.00159	0.00392	CcSEcCtD
Epirubicin—Vasodilation—Thalidomide—leprosy	0.00159	0.00392	CcSEcCtD
Epirubicin—Amenorrhoea—Thalidomide—leprosy	0.00159	0.00392	CcSEcCtD
Epirubicin—PLA2G4A—tendon—leprosy	0.00159	0.0375	CbGeAlD
Epirubicin—Photosensitivity reaction—Dapsone—leprosy	0.00156	0.00385	CcSEcCtD
Epirubicin—Bone disorder—Thalidomide—leprosy	0.00155	0.00381	CcSEcCtD
Epirubicin—Viral infection—Thalidomide—leprosy	0.00155	0.00381	CcSEcCtD
Epirubicin—Skin discolouration—Thalidomide—leprosy	0.00155	0.00381	CcSEcCtD
Epirubicin—Hyperbilirubinaemia—Thalidomide—leprosy	0.00154	0.00378	CcSEcCtD
Epirubicin—Arthropathy—Thalidomide—leprosy	0.00154	0.00378	CcSEcCtD
Epirubicin—Cellulitis—Thalidomide—leprosy	0.00154	0.00378	CcSEcCtD
Epirubicin—Hypocalcaemia—Thalidomide—leprosy	0.00153	0.00376	CcSEcCtD
Epirubicin—Thinking abnormal—Thalidomide—leprosy	0.00153	0.00376	CcSEcCtD
Epirubicin—Oliguria—Thalidomide—leprosy	0.00152	0.00373	CcSEcCtD
Epirubicin—Herpes simplex—Thalidomide—leprosy	0.00152	0.00373	CcSEcCtD
Epirubicin—TOP2A—tendon—leprosy	0.00151	0.0357	CbGeAlD
Epirubicin—Hyperuricaemia—Thalidomide—leprosy	0.00151	0.00371	CcSEcCtD
Epirubicin—Neuropathy peripheral—Dapsone—leprosy	0.0015	0.00369	CcSEcCtD
Epirubicin—Dyskinesia—Thalidomide—leprosy	0.00149	0.00366	CcSEcCtD
Epirubicin—Creatinine increased—Thalidomide—leprosy	0.00147	0.00362	CcSEcCtD
Epirubicin—Bone pain—Thalidomide—leprosy	0.00146	0.00359	CcSEcCtD
Epirubicin—Atrioventricular block—Thalidomide—leprosy	0.00144	0.00355	CcSEcCtD
Epirubicin—Sinusitis—Dapsone—leprosy	0.00143	0.00353	CcSEcCtD
Epirubicin—Gait disturbance—Thalidomide—leprosy	0.00143	0.00353	CcSEcCtD
Epirubicin—Blood uric acid increased—Thalidomide—leprosy	0.00142	0.0035	CcSEcCtD
Epirubicin—Coordination abnormal—Thalidomide—leprosy	0.00142	0.0035	CcSEcCtD
Epirubicin—Neck pain—Thalidomide—leprosy	0.00141	0.00348	CcSEcCtD
Epirubicin—Pulmonary embolism—Thalidomide—leprosy	0.0014	0.00344	CcSEcCtD
Epirubicin—Hepatocellular injury—Thalidomide—leprosy	0.0014	0.00344	CcSEcCtD
Epirubicin—Phosphatase alkaline increased—Thalidomide—leprosy	0.0014	0.00344	CcSEcCtD
Epirubicin—Eructation—Thalidomide—leprosy	0.00137	0.00338	CcSEcCtD
Epirubicin—Hyperkalaemia—Thalidomide—leprosy	0.00137	0.00338	CcSEcCtD
Epirubicin—Pharyngitis—Dapsone—leprosy	0.00136	0.00335	CcSEcCtD
Epirubicin—Colitis—Thalidomide—leprosy	0.00134	0.0033	CcSEcCtD
Epirubicin—Candida infection—Thalidomide—leprosy	0.00133	0.00329	CcSEcCtD
Epirubicin—Skin exfoliation—Thalidomide—leprosy	0.00133	0.00329	CcSEcCtD
Epirubicin—Blood urea increased—Thalidomide—leprosy	0.00132	0.00325	CcSEcCtD
Epirubicin—PLA2G4A—testis—leprosy	0.00131	0.0311	CbGeAlD
Epirubicin—Neuropathy—Thalidomide—leprosy	0.00131	0.00323	CcSEcCtD
Epirubicin—Aplastic anaemia—Thalidomide—leprosy	0.00131	0.00323	CcSEcCtD
Epirubicin—Dry eye—Thalidomide—leprosy	0.00129	0.00318	CcSEcCtD
Epirubicin—PLA2G4A—nervous system—leprosy	0.00129	0.0305	CbGeAlD
Epirubicin—Cramps of lower extremities—Thalidomide—leprosy	0.00128	0.00316	CcSEcCtD
Epirubicin—Tinnitus—Dapsone—leprosy	0.00128	0.00315	CcSEcCtD
Epirubicin—Oesophagitis—Thalidomide—leprosy	0.00128	0.00314	CcSEcCtD
Epirubicin—Rash maculo-papular—Thalidomide—leprosy	0.00127	0.00313	CcSEcCtD
Epirubicin—TOP2A—testis—leprosy	0.00125	0.0295	CbGeAlD
Epirubicin—Pulmonary oedema—Thalidomide—leprosy	0.00124	0.00306	CcSEcCtD
Epirubicin—Hypertonia—Thalidomide—leprosy	0.00122	0.00302	CcSEcCtD
Epirubicin—Mental disability—Thalidomide—leprosy	0.00121	0.00299	CcSEcCtD
Epirubicin—Sepsis—Thalidomide—leprosy	0.00121	0.00299	CcSEcCtD
Epirubicin—Erythema—Dapsone—leprosy	0.00119	0.00294	CcSEcCtD
Epirubicin—Lymphadenopathy—Thalidomide—leprosy	0.00119	0.00293	CcSEcCtD
Epirubicin—Thrombophlebitis—Thalidomide—leprosy	0.00117	0.00289	CcSEcCtD
Epirubicin—Diabetes mellitus—Thalidomide—leprosy	0.00117	0.00287	CcSEcCtD
Epirubicin—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00117	0.00287	CcSEcCtD
Epirubicin—Photosensitivity—Thalidomide—leprosy	0.00115	0.00284	CcSEcCtD
Epirubicin—Vascular purpura—Thalidomide—leprosy	0.00113	0.00279	CcSEcCtD
Epirubicin—Eczema—Thalidomide—leprosy	0.00113	0.00278	CcSEcCtD
Epirubicin—Vision blurred—Dapsone—leprosy	0.00112	0.00277	CcSEcCtD
Epirubicin—Eye pain—Thalidomide—leprosy	0.00112	0.00277	CcSEcCtD
Epirubicin—Cardiac failure congestive—Thalidomide—leprosy	0.00112	0.00275	CcSEcCtD
Epirubicin—Renal failure acute—Thalidomide—leprosy	0.0011	0.00271	CcSEcCtD
Epirubicin—Increased appetite—Thalidomide—leprosy	0.00108	0.00266	CcSEcCtD
Epirubicin—Dermatitis exfoliative—Thalidomide—leprosy	0.00107	0.00265	CcSEcCtD
Epirubicin—Vertigo—Dapsone—leprosy	0.00107	0.00264	CcSEcCtD
Epirubicin—Dermatitis bullous—Thalidomide—leprosy	0.00106	0.00261	CcSEcCtD
Epirubicin—Purpura—Thalidomide—leprosy	0.00105	0.00259	CcSEcCtD
Epirubicin—Cough—Dapsone—leprosy	0.00104	0.00256	CcSEcCtD
Epirubicin—Hypoglycaemia—Thalidomide—leprosy	0.00104	0.00256	CcSEcCtD
Epirubicin—Cardiac failure—Thalidomide—leprosy	0.00104	0.00256	CcSEcCtD
Epirubicin—Lethargy—Thalidomide—leprosy	0.00103	0.00255	CcSEcCtD
Epirubicin—Cerebrovascular accident—Thalidomide—leprosy	0.00103	0.00255	CcSEcCtD
Epirubicin—Hyponatraemia—Thalidomide—leprosy	0.00102	0.00251	CcSEcCtD
Epirubicin—Pain in extremity—Thalidomide—leprosy	0.00101	0.0025	CcSEcCtD
Epirubicin—Diplopia—Thalidomide—leprosy	0.00101	0.0025	CcSEcCtD
Epirubicin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00101	0.0025	CcSEcCtD
Epirubicin—Osteoarthritis—Thalidomide—leprosy	0.00101	0.0025	CcSEcCtD
Epirubicin—Affect lability—Thalidomide—leprosy	0.000998	0.00246	CcSEcCtD
Epirubicin—Migraine—Thalidomide—leprosy	0.000998	0.00246	CcSEcCtD
Epirubicin—Face oedema—Thalidomide—leprosy	0.000979	0.00241	CcSEcCtD
Epirubicin—Cardiac arrest—Thalidomide—leprosy	0.000964	0.00238	CcSEcCtD
Epirubicin—Mood swings—Thalidomide—leprosy	0.00096	0.00237	CcSEcCtD
Epirubicin—Ataxia—Thalidomide—leprosy	0.000953	0.00235	CcSEcCtD
Epirubicin—Tachycardia—Dapsone—leprosy	0.00095	0.00234	CcSEcCtD
Epirubicin—Blood creatinine increased—Thalidomide—leprosy	0.00095	0.00234	CcSEcCtD
Epirubicin—Dehydration—Thalidomide—leprosy	0.000943	0.00232	CcSEcCtD
Epirubicin—Liver function test abnormal—Thalidomide—leprosy	0.000936	0.00231	CcSEcCtD
Epirubicin—Dry skin—Thalidomide—leprosy	0.000929	0.00229	CcSEcCtD
Epirubicin—Orthostatic hypotension—Thalidomide—leprosy	0.000926	0.00228	CcSEcCtD
Epirubicin—Hypokalaemia—Thalidomide—leprosy	0.000923	0.00227	CcSEcCtD
Epirubicin—Breast disorder—Thalidomide—leprosy	0.000916	0.00226	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000913	0.00225	CcSEcCtD
Epirubicin—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000913	0.00225	CcSEcCtD
Epirubicin—ABCC1—tendon—leprosy	0.000908	0.0215	CbGeAlD
Epirubicin—Alanine aminotransferase increased—Thalidomide—leprosy	0.000894	0.0022	CcSEcCtD
Epirubicin—Muscular weakness—Thalidomide—leprosy	0.000894	0.0022	CcSEcCtD
Epirubicin—Abdominal distension—Thalidomide—leprosy	0.000882	0.00217	CcSEcCtD
Epirubicin—Insomnia—Dapsone—leprosy	0.00088	0.00217	CcSEcCtD
Epirubicin—Influenza—Thalidomide—leprosy	0.000876	0.00216	CcSEcCtD
Epirubicin—Dysphagia—Thalidomide—leprosy	0.000876	0.00216	CcSEcCtD
Epirubicin—Eosinophilia—Thalidomide—leprosy	0.000867	0.00214	CcSEcCtD
Epirubicin—Pancreatitis—Thalidomide—leprosy	0.000859	0.00212	CcSEcCtD
Epirubicin—Angina pectoris—Thalidomide—leprosy	0.000853	0.0021	CcSEcCtD
Epirubicin—Bronchitis—Thalidomide—leprosy	0.000843	0.00208	CcSEcCtD
Epirubicin—Pancytopenia—Thalidomide—leprosy	0.000832	0.00205	CcSEcCtD
Epirubicin—Neutropenia—Thalidomide—leprosy	0.000819	0.00202	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Thalidomide—leprosy	0.000814	0.00201	CcSEcCtD
Epirubicin—Pollakiuria—Thalidomide—leprosy	0.000809	0.00199	CcSEcCtD
Epirubicin—Photosensitivity reaction—Thalidomide—leprosy	0.0008	0.00197	CcSEcCtD
Epirubicin—Weight increased—Thalidomide—leprosy	0.000797	0.00196	CcSEcCtD
Epirubicin—Gastrointestinal pain—Dapsone—leprosy	0.000796	0.00196	CcSEcCtD
Epirubicin—Weight decreased—Thalidomide—leprosy	0.000793	0.00195	CcSEcCtD
Epirubicin—Hyperglycaemia—Thalidomide—leprosy	0.00079	0.00195	CcSEcCtD
Epirubicin—Pneumonia—Thalidomide—leprosy	0.000786	0.00194	CcSEcCtD
Epirubicin—Infestation—Thalidomide—leprosy	0.000781	0.00193	CcSEcCtD
Epirubicin—Drowsiness—Thalidomide—leprosy	0.000781	0.00193	CcSEcCtD
Epirubicin—Infestation NOS—Thalidomide—leprosy	0.000781	0.00193	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000774	0.00191	CcSEcCtD
Epirubicin—Body temperature increased—Dapsone—leprosy	0.000769	0.0019	CcSEcCtD
Epirubicin—Abdominal pain—Dapsone—leprosy	0.000769	0.0019	CcSEcCtD
Epirubicin—Renal failure—Thalidomide—leprosy	0.000768	0.00189	CcSEcCtD
Epirubicin—Neuropathy peripheral—Thalidomide—leprosy	0.000766	0.00189	CcSEcCtD
Epirubicin—Stomatitis—Thalidomide—leprosy	0.000761	0.00188	CcSEcCtD
Epirubicin—Conjunctivitis—Thalidomide—leprosy	0.000759	0.00187	CcSEcCtD
Epirubicin—ABCC1—testis—leprosy	0.000752	0.0178	CbGeAlD
Epirubicin—Sweating—Thalidomide—leprosy	0.000749	0.00185	CcSEcCtD
Epirubicin—Haematuria—Thalidomide—leprosy	0.000745	0.00184	CcSEcCtD
Epirubicin—Epistaxis—Thalidomide—leprosy	0.000737	0.00182	CcSEcCtD
Epirubicin—Sinusitis—Thalidomide—leprosy	0.000733	0.00181	CcSEcCtD
Epirubicin—Agranulocytosis—Thalidomide—leprosy	0.000729	0.0018	CcSEcCtD
Epirubicin—Bradycardia—Thalidomide—leprosy	0.000714	0.00176	CcSEcCtD
Epirubicin—Rhinitis—Thalidomide—leprosy	0.000703	0.00173	CcSEcCtD
Epirubicin—Hepatitis—Thalidomide—leprosy	0.000701	0.00173	CcSEcCtD
Epirubicin—Hypoaesthesia—Thalidomide—leprosy	0.000698	0.00172	CcSEcCtD
Epirubicin—Pharyngitis—Thalidomide—leprosy	0.000696	0.00172	CcSEcCtD
Epirubicin—Urinary tract disorder—Thalidomide—leprosy	0.000693	0.00171	CcSEcCtD
Epirubicin—Oedema peripheral—Thalidomide—leprosy	0.000691	0.0017	CcSEcCtD
Epirubicin—Urethral disorder—Thalidomide—leprosy	0.000687	0.00169	CcSEcCtD
Epirubicin—Visual impairment—Thalidomide—leprosy	0.000676	0.00167	CcSEcCtD
Epirubicin—Erythema multiforme—Thalidomide—leprosy	0.000663	0.00163	CcSEcCtD
Epirubicin—Eye disorder—Thalidomide—leprosy	0.000655	0.00161	CcSEcCtD
Epirubicin—Tinnitus—Thalidomide—leprosy	0.000654	0.00161	CcSEcCtD
Epirubicin—Cardiac disorder—Thalidomide—leprosy	0.000651	0.0016	CcSEcCtD
Epirubicin—Angiopathy—Thalidomide—leprosy	0.000636	0.00157	CcSEcCtD
Epirubicin—Immune system disorder—Thalidomide—leprosy	0.000633	0.00156	CcSEcCtD
Epirubicin—Mediastinal disorder—Thalidomide—leprosy	0.000632	0.00156	CcSEcCtD
Epirubicin—Chills—Thalidomide—leprosy	0.000629	0.00155	CcSEcCtD
Epirubicin—Arrhythmia—Thalidomide—leprosy	0.000626	0.00154	CcSEcCtD
Epirubicin—Alopecia—Thalidomide—leprosy	0.00062	0.00153	CcSEcCtD
Epirubicin—Vomiting—Dapsone—leprosy	0.000619	0.00152	CcSEcCtD
Epirubicin—Mental disorder—Thalidomide—leprosy	0.000614	0.00151	CcSEcCtD
Epirubicin—Malnutrition—Thalidomide—leprosy	0.00061	0.0015	CcSEcCtD
Epirubicin—Headache—Dapsone—leprosy	0.00061	0.0015	CcSEcCtD
Epirubicin—Flatulence—Thalidomide—leprosy	0.000602	0.00148	CcSEcCtD
Epirubicin—Tension—Thalidomide—leprosy	0.000599	0.00148	CcSEcCtD
Epirubicin—Dysgeusia—Thalidomide—leprosy	0.000598	0.00147	CcSEcCtD
Epirubicin—Nervousness—Thalidomide—leprosy	0.000593	0.00146	CcSEcCtD
Epirubicin—Back pain—Thalidomide—leprosy	0.000591	0.00146	CcSEcCtD
Epirubicin—Muscle spasms—Thalidomide—leprosy	0.000587	0.00145	CcSEcCtD
Epirubicin—Nausea—Dapsone—leprosy	0.000578	0.00142	CcSEcCtD
Epirubicin—Vision blurred—Thalidomide—leprosy	0.000575	0.00142	CcSEcCtD
Epirubicin—Ill-defined disorder—Thalidomide—leprosy	0.000566	0.0014	CcSEcCtD
Epirubicin—Anaemia—Thalidomide—leprosy	0.000564	0.00139	CcSEcCtD
Epirubicin—Agitation—Thalidomide—leprosy	0.000561	0.00138	CcSEcCtD
Epirubicin—Malaise—Thalidomide—leprosy	0.000551	0.00136	CcSEcCtD
Epirubicin—Vertigo—Thalidomide—leprosy	0.000548	0.00135	CcSEcCtD
Epirubicin—Syncope—Thalidomide—leprosy	0.000547	0.00135	CcSEcCtD
Epirubicin—Leukopenia—Thalidomide—leprosy	0.000546	0.00135	CcSEcCtD
Epirubicin—Palpitations—Thalidomide—leprosy	0.000539	0.00133	CcSEcCtD
Epirubicin—Loss of consciousness—Thalidomide—leprosy	0.000537	0.00132	CcSEcCtD
Epirubicin—Cough—Thalidomide—leprosy	0.000533	0.00131	CcSEcCtD
Epirubicin—Convulsion—Thalidomide—leprosy	0.000529	0.0013	CcSEcCtD
Epirubicin—Hypertension—Thalidomide—leprosy	0.000527	0.0013	CcSEcCtD
Epirubicin—Chest pain—Thalidomide—leprosy	0.00052	0.00128	CcSEcCtD
Epirubicin—Myalgia—Thalidomide—leprosy	0.00052	0.00128	CcSEcCtD
Epirubicin—Arthralgia—Thalidomide—leprosy	0.00052	0.00128	CcSEcCtD
Epirubicin—Anxiety—Thalidomide—leprosy	0.000518	0.00128	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000516	0.00127	CcSEcCtD
Epirubicin—Discomfort—Thalidomide—leprosy	0.000514	0.00127	CcSEcCtD
Epirubicin—Dry mouth—Thalidomide—leprosy	0.000508	0.00125	CcSEcCtD
Epirubicin—Confusional state—Thalidomide—leprosy	0.000502	0.00124	CcSEcCtD
Epirubicin—Oedema—Thalidomide—leprosy	0.000498	0.00123	CcSEcCtD
Epirubicin—Infection—Thalidomide—leprosy	0.000495	0.00122	CcSEcCtD
Epirubicin—Shock—Thalidomide—leprosy	0.00049	0.00121	CcSEcCtD
Epirubicin—Nervous system disorder—Thalidomide—leprosy	0.000489	0.0012	CcSEcCtD
Epirubicin—Thrombocytopenia—Thalidomide—leprosy	0.000488	0.0012	CcSEcCtD
Epirubicin—Tachycardia—Thalidomide—leprosy	0.000486	0.0012	CcSEcCtD
Epirubicin—Skin disorder—Thalidomide—leprosy	0.000484	0.00119	CcSEcCtD
Epirubicin—Hyperhidrosis—Thalidomide—leprosy	0.000482	0.00119	CcSEcCtD
Epirubicin—Anorexia—Thalidomide—leprosy	0.000475	0.00117	CcSEcCtD
Epirubicin—Hypotension—Thalidomide—leprosy	0.000466	0.00115	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Thalidomide—leprosy	0.000454	0.00112	CcSEcCtD
Epirubicin—Insomnia—Thalidomide—leprosy	0.000451	0.00111	CcSEcCtD
Epirubicin—Paraesthesia—Thalidomide—leprosy	0.000447	0.0011	CcSEcCtD
Epirubicin—Dyspnoea—Thalidomide—leprosy	0.000444	0.00109	CcSEcCtD
Epirubicin—Somnolence—Thalidomide—leprosy	0.000443	0.00109	CcSEcCtD
Epirubicin—Dyspepsia—Thalidomide—leprosy	0.000439	0.00108	CcSEcCtD
Epirubicin—Decreased appetite—Thalidomide—leprosy	0.000433	0.00107	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Thalidomide—leprosy	0.00043	0.00106	CcSEcCtD
Epirubicin—Fatigue—Thalidomide—leprosy	0.00043	0.00106	CcSEcCtD
Epirubicin—Pain—Thalidomide—leprosy	0.000426	0.00105	CcSEcCtD
Epirubicin—Constipation—Thalidomide—leprosy	0.000426	0.00105	CcSEcCtD
Epirubicin—Feeling abnormal—Thalidomide—leprosy	0.000411	0.00101	CcSEcCtD
Epirubicin—Gastrointestinal pain—Thalidomide—leprosy	0.000407	0.001	CcSEcCtD
Epirubicin—Urticaria—Thalidomide—leprosy	0.000396	0.000975	CcSEcCtD
Epirubicin—Body temperature increased—Thalidomide—leprosy	0.000394	0.000971	CcSEcCtD
Epirubicin—Abdominal pain—Thalidomide—leprosy	0.000394	0.000971	CcSEcCtD
Epirubicin—Hypersensitivity—Thalidomide—leprosy	0.000367	0.000905	CcSEcCtD
Epirubicin—Asthenia—Thalidomide—leprosy	0.000357	0.000881	CcSEcCtD
Epirubicin—Pruritus—Thalidomide—leprosy	0.000352	0.000869	CcSEcCtD
Epirubicin—Diarrhoea—Thalidomide—leprosy	0.000341	0.00084	CcSEcCtD
Epirubicin—Dizziness—Thalidomide—leprosy	0.000329	0.000812	CcSEcCtD
Epirubicin—Vomiting—Thalidomide—leprosy	0.000317	0.000781	CcSEcCtD
Epirubicin—Rash—Thalidomide—leprosy	0.000314	0.000774	CcSEcCtD
Epirubicin—Dermatitis—Thalidomide—leprosy	0.000314	0.000773	CcSEcCtD
Epirubicin—Headache—Thalidomide—leprosy	0.000312	0.000769	CcSEcCtD
Epirubicin—Nausea—Thalidomide—leprosy	0.000296	0.000729	CcSEcCtD
